Mechanical thrombectomy reduced right ventricular strain more than anticoagulation alone in intermediate-high risk pulmonary embolism.
Nonurban patients with suspected LVO who receive direct transportation to a thrombectomy-capable center have better functional outcomes.
Alteplase, a “clot-buster” medication used to treat ischemic stroke, acute myocardial infarctions, and acute pulmonary ...
With the study adding to a mix of conflicting trial results, it’s not yet time to update guidelines, Shyam Prabhakaran says.
Vesalio expanded its neurovascular portfolio today after earning CE mark certification for two new devices: NeVa VS and Neva 3.0 mm.
Giving the clot-busting medication alteplase at the site of a blocked brain artery after blood clot removal may increase the ...
Rapid Medical announced late-breaking results from the DISTALS trial evaluating the company’s Tigertriever 13 device for ...
Delivering intra-arterial alteplase after successful mechanical thrombectomy improved functional recovery in patients with larg ...
SonoVascular announced today that it has completed the first close of its $6 million Series A financing round.
The life-saving treatment can prevent avoidable death and long-term disability ...
AIM: The “2026 Guideline for the Early Management of Patients With AIS” replaces the “2018 Guidelines for the Early Management of Patients With AIS” and the 2019 update to reflect recent advances in ...